SPA
NEO icon

Sherbrooke Park Advisers’s NeoGenomics NEO Stock Holding History

Sherbrooke Park Advisers’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-11,102
Closed -$183K – 826
2024
Q4 		$183K Buy
+11,102
New +$172K 0.06% 604

Other funds holding NEO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $2.23B AUM 12.38% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Sherbrooke Park Advisers's NEO Position: Q1 2025 in Review

Sherbrooke Park Advisers sold out of NeoGenomics (NEO) in Q1 2025, closing a stake of 11,102 shares — an estimated $183K sold.

Sherbrooke Park Advisers first reported a position in NEO in Q4 2024 and held it in 1 quarter. The position peaked at $183K in Q4 2024. 256 funds tracked by Wall St. Rank hold NEO as of Q1 2025.

  • Sherbrooke Park Advisers reported no remaining NeoGenomics position as of Q1 2025 after selling out during the quarter.
  • Sherbrooke Park Advisers sold 11,102 NeoGenomics shares in Q1 2025, an estimated $183K.
  • Sherbrooke Park Advisers first reported a position in NeoGenomics in Q4 2024 and held it in 1 quarter.
  • Sherbrooke Park Advisers's NeoGenomics position peaked at $183K in Q4 2024.
  • 256 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2025.

Based on Sherbrooke Park Advisers's 13F filing for Q1 2025, filed 15 May 2025.